MRP4 (ABCC4) as a potential pharmacologic target for cardiovascular disease

Keyphrases

• Cardiovascular Disease 100%
• Pharmacologic Targets 100%
• ABCC4 100%
• Mrp4 100%
• Platelets 25%
• Cardiac Hypertrophy 25%
• Proliferation in Vitro 25%
• Pharmacological Inhibitors 12%
• Therapeutic Potential 12%
• Platelet Function 12%
• Adult Rats 12%
• Homeostasis 12%
• Regulatory Mechanism 12%
• Atherothrombotic Disease 12%
• Adenylate Cyclase 12%
• Pulmonary Hypertension 12%
• Platelet Activation 12%
• Compartmentalization 12%
• Vascular System 12%
• Platelet Dense Granules 12%
• Vascular Biology 12%
• Adenosine 12%
• Cardiac Fibrosis 12%
• Smooth muscle Cell Proliferation 12%
• Antiplatelet Activity 12%
• Mouse in Vivo 12%
• Rat Ventricular Myocytes 12%
• HCASMC 12%
• Intracellular cAMP Level 12%
• Human Pulmonary Artery Smooth muscle Cells 12%
• Cardiomyocyte Contractility 12%
• Pulmonary Artery Smooth muscle Cell Proliferation 12%
• Thrombopathy 12%

Medicine and Dentistry

• Cardiovascular Disease 100%
• Multidrug Resistance Associated Protein 4 100%
• Platelet 37%
• Cell Proliferation 25%
• Ventricular Hypertrophy 25%
• In Vitro 25%
• Disease 12%
• Antiplatelet 12%
• Coronary Artery 12%
• Metabolite 12%
• Thrombocyte Function 12%
• Adenosine 12%
• Smooth Muscle Cell 12%
• Pulmonary Hypertension 12%
• Muscle Contractility 12%
• Homeostasis 12%
• Vascular System 12%
• Thrombocyte Activation 12%
• Dense Granule 12%
• Cardiac Muscle Cell 12%
• Vascular Biology 12%
• Cardiac Fibrosis 12%
• Adenylate Cyclase 12%
• Pulmonary Artery Smooth Muscle Cell 12%
• Thrombocyte Anomaly 12%
• Multidrug Resistance Protein 4 12%
• Muscle Cell 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Multidrug Resistance Associated Protein 4 100%
• Cardiovascular Disease 100%
• Heart Ventricle Hypertrophy 25%
• Disease 12%
• Antiplatelet 12%
• Adenosine 12%
• Pulmonary Hypertension 12%
• Heart Muscle Fibrosis 12%
• Adenylate Cyclase 12%
• Thrombocyte Anomaly 12%
• Multidrug Resistance Protein 4 12%